Short Term Stocks with Analyst Upgrades

 Bullish.Bets
 
  Bullish.Bets
 
Follow  Message
 
 
 
Bullish.Bets focuses on stocks poised for explosive moves up or down, scanning volatility, catalysts, and sentiment shifts to uncover high-impact trading opportunities
 

•  29 Dec 2025
 

•   BMO  
   
  0.00%
•   HAS  
   
  0.00%
•   MFC  
   
  0.00%
•   NCNO  
   
  0.00%
•   NEM  
   
  0.00%

$RARE Ultragenyx Pharma is trading near its 52-week lows after failed trials, yet analysts still point to 138.34% upside to the revised $47 target. That gap reflects confidence in the broader rare-disease pipeline despite recent setbacks. With expectations reset and volume elevated, even incremental clinical progress or sentiment stabilization could trigger a sharp relief rally, making this a high-volatility rebound candidate.

$BMO Bank of Montreal offers a more defensive setup with 40.20% upside to the $184 target following a modest increase while the Hold rating was maintained. Analysts appear comfortable with earnings resilience, capital strength, and dividend stability after a rebound in profitability. Trading near 52-week highs limits momentum breakouts, but the valuation gap supports steady appreciation rather than aggressive short-term moves.

$MFC Manulife Financial combines income appeal with 39.08% upside to the $51 target after Morgan Stanley lifted estimates. Analysts cite improving fundamentals and sensitivity to interest-rate dynamics as key drivers. While not a momentum stock, the gap to target leaves room for further gains if macro conditions remain supportive.

$NCNO nCino stands out among growth names with 32.10% upside implied by consensus targets near $34.58. Improving earnings revisions and continued adoption of cloud banking solutions underpin the bullish view. After pulling back from its highs, the stock could see renewed interest if execution remains consistent, positioning it as a solid short-term recovery candidate tied to tech sentiment.

$HAS Hasbro’s thesis points to 14.82% upside to the $95 target, driven largely by continued strength in Magic: The Gathering. The recent target raise reflects confidence in franchise monetization rather than a full business turnaround. Upside appears incremental but supported by reliable cash flow and brand durability.

$NEM Newmont shows 11.21% upside to the $111 target after a raise from Raymond James, highlighting leverage to gold prices and asset quality. With the stock trading near recent highs, further gains are likely to depend more on gold market momentum than on company-specific catalysts, making this a macro-sensitive trade.

View All Headlines